Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online March 27, 2008
Stem Cells Vol. 26 No. 6 June 2008, pp. 1620 -1627
doi:10.1634/stemcells.2008-0161; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2008-0161v1
2008-0161v2
26/6/1620    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tesio, M.
Right arrow Articles by Piacibello, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tesio, M.
Right arrow Articles by Piacibello, W.

TISSUE-SPECIFIC STEM CELLS

Sustained Long-Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors

Melania Tesioa, Loretta Gammaitonia, Monica Gunettib, Valeria Leucia, Ymera Pignochinoa, Noela Jordaneya, Sonia Capelleroa, Cristina Cammarataa, Luisa Caionea, Giuseppe Migliarettic, Franca Fagiolib, Antonio Tabiliod,e, Massimo Agliettaa, Wanda Piacibelloa

aLaboratory of Clinical Oncology, Department of Oncological Sciences, University of Torino Medical School, Institute for Cancer Research and Treatment, Candiolo (Torino) Italy;
cDepartment of Public Health and Microbiology, University of Torino Medical School, Torino, Italy;
bPediatric Onco-Haematology Unit, Stem Cell Transplantation and Cellular Therapy Center, Regina Margherita Children's Hospital, Torino, Italy;
dHematology and Clinical Immunology Section and
eInternal Medicine and Oncological Science Section, University of Perugia, Perugia, Italy

Key Words. Ex vivo gene transfer • Hematopoietic stem cells • Enhanced green fluorescent protein • Expansion • Mobilized peripheral blood

Correspondence: Wanda Piacibello, M.D., Laboratory of Clinical Oncology, IRCC Institute for Cancer Research and Treatment, Provinciale 142, 10060 Candiolo, Torino, Italy. Telephone: 390119933349; Fax: 390119933522; e-mail: wanda.piacibello{at}ircc.it

Received February 19, 2008; accepted for publication March 14, 2008.
First published online in STEM CELLS EXPRESS   March 27, 2008.



As mobilized peripheral blood (MPB) represents an attractive cell source for gene therapy, we investigated the ability of third-generation lentiviral vectors (LVs) to transfer the enhanced green fluorescent protein gene into MPB CD34+ cells in culture conditions allowing expansion of transplantable human hematopoietic stem cells. To date, few studies have reported transduction of MPB cells with vesicular stomatitis virus G pseudotyped LVs. The critical issue remains whether primitive, hematopoietic repopulating cells have, indeed, been transduced. In vitro (5 weeks' culture in FLT3 ligand + thrombopoietin + stem cell factor + interleukin 6) and in vivo (serial transplantation in NOD/SCID mice) experiments show that MPB CD34+ cells can be effectively long-term transduced by LV and maintain their proliferation, self-renewal, and multilineage differentiation potentials. We show that expansion following transduction improves the engraftment of transduced MPB CD34+ (4.6-fold expansion of SCID repopulating cells by limiting dilution studies). We propose ex vivo expansion after transduction as an effective tool to improve gene therapy protocols with MPB.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.